| 000 | 01740 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517160931.0 | ||
| 264 | 0 | _c20180723 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1525-1594 | ||
| 024 | 7 |
_a10.1111/aor.12910 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBitar, Abbas | |
| 245 | 0 | 0 |
_aThe Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices. _h[electronic resource] |
| 260 |
_bArtificial organs _cDec 2017 |
||
| 300 |
_a1092-1098 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 | _aEptifibatide |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xcomplications |
| 650 | 0 | 4 |
_aHeart-Assist Devices _xadverse effects |
| 650 | 0 | 4 |
_aHemolysis _xdrug effects |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptides _xtherapeutic use |
| 650 | 0 | 4 |
_aPipecolic Acids _xtherapeutic use |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSulfonamides |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 650 | 0 | 4 |
_aWarfarin _xtherapeutic use |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aVijayakrishnan, Rajakrishnan | |
| 700 | 1 | _aLenneman, Andrew | |
| 700 | 1 | _aBirks, Emma | |
| 700 | 1 | _aMassey, Todd | |
| 700 | 1 | _aSlaughter, Mark | |
| 700 | 1 | _aAbramov, Dmitry | |
| 773 | 0 |
_tArtificial organs _gvol. 41 _gno. 12 _gp. 1092-1098 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/aor.12910 _zAvailable from publisher's website |
| 999 |
_c27284173 _d27284173 |
||